MTFB Motif Bio Plc

TIDMMTFB

RNS Number : 7683U

Motif Bio PLC

27 November 2019

Motif Bio plc

("Motif Bio" or the "Company")

American Depositary Shares ("ADS") Program and Warrant Agent Agreement

Motif Bio plc (AIM/Nasdaq: MTFB) announces, that further to the announcement yesterday of the Company's intention to voluntarily delist its American Depository Shares (ADSs), it has given notice on November 26, 2019 to The Bank of New York Mellon to terminate its American Depositary Shares ("ADS") Program and Warrant Agent Agreement.

The Depositary will contact ADS holders in due course with additional information on this process, including those necessary and proper actions to be executed.

For further information please contact:

 
                                                            ir@motifbio.com 
   Motif Bio plc 
 Graham Lumsden (Chief Executive Officer) 
 
 SP Angel Corporate Finance LLP (NOMAD 
  & BROKER)                                             +44 (0)20 3470 0470 
 David Hignell/Caroline Rowe (Corporate 
  Finance) 
  Vadim Alexandre/Abigail Wayne (Sales 
  & Broking) 
 
 Walbrook PR Ltd. (UK FINANCIAL PR 
  & IR)                                                 +44 (0)20 7933 8780 
 Paul McManus/Lianne Cawthorne                      motifbio@walbrookpr.com 
 
 MC Services AG (EUROPEAN IR)                            +49 (0)89 210 2280 
 Raimund Gabriel                             raimund.gabriel@mc-services.eu 
 

Forward-Looking Statements

When used in this Press Release, the words or phrases "intends," "anticipates," "expected to be" or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties including, but not limited to, changes in economic conditions in the Company's market area, changes in policies by regulatory agencies, fluctuations in interest rates, competition that could cause actual results to differ materially from historical earnings and those presently anticipated or projected, and other risks described in the Company's filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company advises readers that the factors listed above could affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements. The Company does not undertake, and specifically disclaims any obligation, to publicly release the result of any revision which may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCCKADBBBDBPDB

(END) Dow Jones Newswires

November 27, 2019 02:01 ET (07:01 GMT)

Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Lug 2023 a Lug 2024